RT Journal Article
SR Electronic
T1 Evaluation of a clinical decision support tool for matching cancer patients to clinical trials using simulation-based research
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.30.21257718
DO 10.1101/2021.05.30.21257718
A1 Gardner, Clarissa
A1 Halligan, Jack
A1 Fontana, Gianluca
A1 Fernandez Crespo, Roberto
A1 Prime, Matthew
A1 Guo, Chaohui
A1 Ekinci, Okan
A1 Ghafur, Saira
A1 Darzi, Ara
YR 2021
UL http://medrxiv.org/content/early/2021/06/01/2021.05.30.21257718.abstract
AB Simulation-based research (SBR) methods have been proposed as an alternative methodology for evaluating digital health solutions; however, applicability remains to be established. This study used SBR to evaluate a clinical decision support (CDS) tool used for matching cancer patients to clinical trials. 25 clinicians and research staff were recruited to match 10 synthetic patient cases to clinical trials using both the CDS tool and publicly available online trial databases. Participants were significantly more likely to report having sufficient time (p = 0.020) and to require less mental effort (p = 0.001) to complete trial matching with the CDS tool. Participants required less time for trial matching using the CDS tool, but the difference was not significant (p = 0.093). Most participants reported that they had sufficient guidance to participate in the simulations (96%). This study demonstrates the use of SBR methods is a feasible approach to evaluating digital health solutions.Competing Interest StatementC.H.G., M.P. and O.E. are currently employees of Roche Diagnostics. C.H.G holds Roche shares. G.F. holds shares in and is a Director at Prova Health, which in turn holds consulting contracts with Roche.Funding StatementThe study was funded by F. Hoffman-La Roche Ltd.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval for this study was sought from and approved by the Imperial College London Research Governance & Integrity Team at the university (ICREC reference: 19IC5457)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analysed during this study are included in this published article (and its supplementary information files).